VYNE Therapeutics Inc. (NASDAQ: VYNE) open the trading on March 04, 2021, with a bit cautious approach as it glided -9.73% to $6.68. During the day, the stock rose to $7.28 and sunk to $6.40 before settling in for the price of $7.40 at the close. Taking a more long-term approach, VYNE posted a 52-week range of $4.00-$17.96.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -30.30%. This publicly-traded company’s shares outstanding now amounts to $41.93 million, simultaneously with a float of $41.87 million. The organization now has a market capitalization sitting at $362.66 million. At the time of writing, stock’s 50-day Moving Average stood at $8.24, while the 200-day Moving Average is $7.37.
VYNE Therapeutics Inc. (VYNE) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. VYNE Therapeutics Inc.’s current insider ownership accounts for 1.30%, in contrast to 44.60% institutional ownership. According to the most recent insider trade that took place on Jan 28, this organization’s 10% Owner bought 4,219,409 shares at the rate of 2.37, making the entire transaction reach 9,999,999 in total value, affecting insider ownership by 27,095,819. Preceding that transaction, on Dec 03, Company’s Director bought 50,000 for 1.71, making the whole transaction’s value amount to 85,425. This particular insider is now the holder of 50,000 in total.
VYNE Therapeutics Inc. (VYNE) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 9/29/2020 suggests? It has posted -$0.6 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.17) by -$0.43. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
VYNE Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -30.30% and is forecasted to reach -1.59 in the upcoming year.
VYNE Therapeutics Inc. (NASDAQ: VYNE) Trading Performance Indicators
Let’s observe the current performance indicators for VYNE Therapeutics Inc. (VYNE). It’s Quick Ratio in the last reported quarter now stands at 3.90. The Stock has managed to achieve an average true range (ATR) of 0.98. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 21.72.
In the same vein, VYNE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -12.77, a figure that is expected to reach -0.53 in the next quarter, and analysts are predicting that it will be -1.59 at the market close of one year from today.
Technical Analysis of VYNE Therapeutics Inc. (VYNE)
[VYNE Therapeutics Inc., VYNE] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 15.67% While, its Average True Range was 0.83.
Raw Stochastic average of VYNE Therapeutics Inc. (VYNE) in the period of the previous 100 days is set at 6.32%, which indicates a major rise in contrast to 5.83% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 64.58% that was lower than 96.20% volatility it exhibited in the past 100-days period.